Mammography business causes ANMR loss

Article

Advanced NMR reported a $1.7 million net loss for its 1995 fiscalyear (end-September), primarily due to losses incurred by itsAdvanced Mammography Systems subsidiary. AMS is awaiting regulatoryclearance to begin marketing a dedicated MR mammography

Advanced NMR reported a $1.7 million net loss for its 1995 fiscalyear (end-September), primarily due to losses incurred by itsAdvanced Mammography Systems subsidiary. AMS is awaiting regulatoryclearance to begin marketing a dedicated MR mammography scanner(SCAN 3/15/95).

Advanced NMR, of Wilmington, MA, said the loss came on revenuesof $8.6 million. ANMR's 1995 fiscal year only included revenuesfor nine months because it changed its fiscal year-end to Sept.30 from Dec. 31 when it merged with imaging services firm MedicalDiagnostics (MDI).

ANMR said the company would have been marginally profitablein fiscal 1995 were it not for losses incurred by Advanced MammographySystems. In addition, ANMR's results included only one month ofrevenue from MDI. ANMR believes MDI will contribute $25 millionin revenue in fiscal 1996.

For the comparable nine months of 1994, ANMR posted revenuesof $5.2 million and a net loss of $1.3 million.

Recent Videos
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
Related Content
© 2025 MJH Life Sciences

All rights reserved.